KalVista Pharmaceuticals Files 10-Q
Ticker: KALV · Form: 10-Q · Filed: Mar 12, 2025 · CIK: 1348911
| Field | Detail |
|---|---|
| Company | Kalvista Pharmaceuticals, Inc. (KALV) |
| Form Type | 10-Q |
| Filed Date | Mar 12, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, pharmaceuticals, financials
TL;DR
KalVista Pharma filed its Q3 10-Q. Financials and business details updated.
AI Summary
KalVista Pharmaceuticals, Inc. filed a 10-Q for the period ending January 31, 2025. The company, formerly known as Carbylan Therapeutics, Inc., is focused on pharmaceutical preparations. Key financial data and business addresses in Cambridge, MA are provided.
Why It Matters
This filing provides a quarterly update on KalVista's financial health and operational status, crucial for investors tracking the company's progress in the pharmaceutical sector.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, KalVista faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 001-36830 — SEC File Number (Identifies the company's filing with the SEC.)
- 02142 — ZIP Code (Part of the company's business address.)
Key Players & Entities
- KalVista Pharmaceuticals, Inc. (company) — Filer of the 10-Q
- 20250131 (date) — End of reporting period
- Carbylan Therapeutics, Inc. (company) — Former company name
- Cambridge, MA (location) — Business address
FAQ
What is the fiscal year end for KalVista Pharmaceuticals, Inc.?
The fiscal year end for KalVista Pharmaceuticals, Inc. is April 30.
What was KalVista Pharmaceuticals, Inc. formerly known as?
KalVista Pharmaceuticals, Inc. was formerly known as Carbylan Therapeutics, Inc. and Carbylan Biosurgery, Inc.
What is the business address of KalVista Pharmaceuticals, Inc.?
The business address is 55 CAMBRIDGE PARKWAY, SUITE 901E, CAMBRIDGE, MA 02142.
What is the SIC code for KalVista Pharmaceuticals, Inc.?
The Standard Industrial Classification (SIC) code is 2834, which corresponds to Pharmaceutical Preparations.
What is the accession number for this 10-Q filing?
The accession number for this 10-Q filing is 0000950170-25-037995.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on March 12, 2025 regarding KalVista Pharmaceuticals, Inc. (KALV).